Neuronal α1/2-adrenergic stimulation of IFN-γ, IL-6, and CXCL-1 in murine spleen in late experimental arthritis

Brain Behav Immun. 2013 Oct:33:80-9. doi: 10.1016/j.bbi.2013.06.003. Epub 2013 Jun 17.

Abstract

Objective: Functional cross-talk exists between sympathetic nerve fibers and cytokine-producing splenic cells in early collagen type II-induced arthritis (CIA) (day 32). These earlier experiments demonstrated exclusively neuronal sympathetic regulation of IFN-γ, CXCL1, IL-6, and TGF-β. However, in late arthritis, the sympathetic influence might change due to loss of sympathetic nerve fibers and appearance of neurotransmitter-producing cells. We aimed to investigate neurotransmitter-dependent regulation of IFN-γ, CXCL1, IL-6, and TGF-β in murine spleen in late CIA.

Methods: Spleens were removed when animals reached day 58 (46-68) after immunization to generate 0.35 mm-thick spleen slices, which were transferred to superfusion microchambers to electrically induce release of neurotransmitters. Using respective neurotransmitter antagonists, effects of released neurotransmitters on cytokine secretion were investigated.

Results: There was electrically induced inhibition of IFN-γ, CXCL1, and IL-6, and stimulation of TGF-β, which was much less pronounced than in early CIA. There existed β adrenergic inhibition of IFN-γ, IL-6, and TGF-β (and stimulation of CXCL1) independent of electrical stimulation (interpreted as non-neuronal). However, there was a neuronal α1/2 adrenergic stimulation of IFN-γ, CXCL1, and IL-6 and, we observed neuronal A1-adenosinergic stimulation of TGF-β.

Conclusions: In the late phase of CIA, non-neuronal modulation of cytokine secretion increases while neuronal regulation strikingly decreases. Particularly, β-adrenergic effects are non-neuronal while α1/2-adrenergic effects are clearly neuronal. We suggest that alterations in sympathetic innervation of the spleen fundamentally change the functional neuroimmune interplay in the spleen of arthritic mice.

Keywords: Chronic experimental arthritis; Cytokines; Neurotransmitters; Spleen; Sympathetic nervous system.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis, Experimental / diagnosis
  • Arthritis, Experimental / immunology*
  • Arthritis, Experimental / pathology
  • Cattle
  • Chemokine CXCL1 / antagonists & inhibitors
  • Chemokine CXCL1 / metabolism*
  • Collagen Type II / administration & dosage
  • Collagen Type II / immunology
  • Concanavalin A / administration & dosage
  • Delayed Diagnosis
  • Electric Stimulation
  • Female
  • Interferon-gamma / antagonists & inhibitors
  • Interferon-gamma / metabolism*
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / metabolism*
  • Mice
  • Mice, Inbred DBA
  • Neural Pathways / immunology
  • Neural Pathways / metabolism
  • Neurons / metabolism
  • Neurons / pathology*
  • Receptor Cross-Talk / immunology
  • Receptors, Adrenergic, alpha-1 / physiology*
  • Receptors, Adrenergic, alpha-2 / physiology*
  • Spleen / immunology*
  • Spleen / metabolism
  • Spleen / pathology
  • Transforming Growth Factor beta / metabolism

Substances

  • Chemokine CXCL1
  • Collagen Type II
  • Cxcl1 protein, mouse
  • Interleukin-6
  • Receptors, Adrenergic, alpha-1
  • Receptors, Adrenergic, alpha-2
  • Transforming Growth Factor beta
  • Concanavalin A
  • Interferon-gamma